Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Free Report) in a report published on Thursday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Evoke Pharma Trading Down 2.2 % NASDAQ:EVOK opened at $0.47 on Thursday. Evoke Pharma has a twelve month low of $0.42 and a twelve month […]